Nose-to-Brain Targeted Mucoadhesive Nanoemulsion for Management of Schizophrenia: Development and Pharmacodynamic Evaluation
- 14 August 2026
- journal article
- research article
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 22 (1) , 55
Abstract
No abstract availableKeywords
Funding Information
- Department of Science and Technology, Ministry of Science and Technology, India (SR/FT/LS-135/2012)
This publication has 35 references indexed in Scilit:
- Carvacrol-based nanoemulsions loaded with dimethyl fumarate intended for nose to brain delivery for treatment of multiple sclerosisDrug Delivery and Translational Research, 2025
- Optimized intranasal delivery of segesterone acetate progestin to the brain using nanoemulsions and microemulsionsDrug Delivery and Translational Research, 2025
- Solubilization techniques used for poorly water-soluble drugsActa Pharmaceutica Sinica B, 2024
- Preparation and evaluation of stable nanofluids for heat transfer application2022
- Nose-to-brain peptide delivery – The potential of nanotechnologyBioorganic & Medicinal Chemistry, 2018
- A Review of Asenapine in the Treatment of Bipolar DisorderClinical Drug Investigation, 2017
- Microemulsion for nasal delivery of Asenapine maleate in treatment of schizophrenia: formulation considerationsJournal of Pharmaceutical Investigation, 2017
- Preparation and in vitro/ex vivo evaluation of nanoemulsion for transnasal delivery of paliperidoneApplied Nanoscience, 2016
- Optimization of curcumin nanoemulsion for intranasal delivery using design of experiment and its toxicity assessmentColloids and Surfaces B: Biointerfaces, 2014
- Different behavioural patterns induced by apomorphine: Evidence that the method of administration determines the behavioural response to the drugEuropean Journal of Pharmacology, 1977